Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients

Plasminogen activating inhibitor-1 (PAI-1) plays crucial roles in the development of various cancers, including melanomas. Indeed, various pro-tumorigenic functions of PAI-1 in cancer progression and metastasis have been widely reported. Among them, PAI-1 is also reported as a key regulator of PD-L1...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kentaro Ohuchi, Yumi Kambayashi, Takanori Hidaka, Taku Fujimura
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://doaj.org/article/f2cdaabb1655498a93333cfcd2e3169c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!